Around 75 medication competitors dependent on synlet quality se

• Posted by Michael Doe October 28, 2021 - Filed in Health - #Report  #healthcare  #pharma  #therapy  #medical  - 769 views

  Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that leverage the principle of synthetic lethality for cancer treatment

   

  To order this 485+ page report, which features 195+ figures and 200+ tables, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-/267.html

   

  The USD 8 billion (by 2030) financial opportunity within the synthetic lethality-based drugs and targets market has been analyzed across the following segments:

  • Type of molecule
  • Small Molecule
  • Biologic

   

  • Target disease indication
  • Breast Cancer
  • Colorectal Cancer
  • Fallopian Tube Cancer
  • Gastric Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Peritoneal Cancer
  • Others

   

  • Type of synlet target
  • APE1 / Ref-1
  • Chk1
  • GLS1
  • PARP
  • Pol θ
  • PP2A
  • Wee1

   

  • Route of administration
  • Oral
  • Intravenous

   

  • Key geographical regions
  • North America
  • Europe
  • Asia Pacific

  • Rest of the World

   

  The https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html, report features the following companies, which we identified to be key players in this domain:

  • AbbVie
  • AstraZeneca
  • AtlasMedx
  • BeiGene
  • Chordia Therapeutics
  • Clovis Oncology
  • GlaxoSmithKline
  • IDEAYA Biosciences
  • Mission Therapeutics
  • Pfizer
  • Repare Therapeutics
  • Sierra Oncology
  • SyntheX Labs

   

  Table of Contents

   

  1. Preface
     
     2. Executive Summary
  2. 
     Introduction to DNA Damage and Repair Systems
     
  3. Introduction to Synthetic Lethality
     
  4. Market Overview
     
  5. Company Profiles
     
  6. Emerging Trends on Social Media
     
  7. Publication Analysis
     
  8. Abstract Analysis
     
  9. Academic Grants Analysis
     
  10. Funding and Investment Analysis
      
  11. Target Benchmark Analysis

   

  1. Role of Companion Diagnostics in Synthetic Lethality

   

  1. Market Forecast
     
  2. Concluding Remarks
     
  3. Executive Insights

   

  1. Appendix 1: Tabulated Data

   

  1. Appendix 2: List of Companies and Organizations

   

   

  To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html

  About Roots Analysis

  Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

   

  Contact Information

  Roots Analysis Private Limited

  Gaurav Chaudhary

  +1 (415) 800 3415

  ben.johnson@rootsanalysis.com

  Facebook - https://www.facebook.com/RootsAnalysis

  LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

  Twitter - https://twitter.com/RootsAnalysis